Amneal Pharmaceuticals   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Bridgewater NJ United States (2002)
Status: No NME R&D (2002)

Organization Overview

First Clinical Trial
2009
NCT01064024
First Marketed Drug
2002
ibuprofen (motrin)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

AMNEAL | Amneal Ireland Limited | AMNEAL PHARM | Amneal Pharmaceuticals, LLC | AMNEAL PHARMS | AMNEAL PHARMS CO | AMNEAL PHARMS LLC | AMNEAL PHARMS NY | IPR